Przejdź do zawartości
Merck

Przejdź do

36-012

Anti-nitro-α/β-Synuclein (Tyr39) Antibody, clone nSyn14

clone nSyn14, Upstate®, from mouse

Synonim(y):

Anti-NACP, Anti-PARK4, Anti-PD1

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

Zmień widok
Gabaryty przesyłkiSKUDostępnośćCena netto
200 μL
Sprawdź dostępność w koszyku
2560,00 zł

Informacje o tej pozycji

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
nSyn14, monoclonal
Species reactivity:
human
Application:
IHC, WB
Citations:
21

2560,00 zł


Sprawdź dostępność w koszyku

Zamów zamówienie zbiorcze
Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomóc


biological source

mouse

Quality Level

antibody form

ascites fluid

antibody product type

primary antibodies

clone

nSyn14, monoclonal

species reactivity

human

manufacturer/tradename

Upstate®

technique(s)

immunohistochemistry: suitable, western blot: suitable

NCBI accession no.

UniProt accession no.

shipped in

dry ice

target post-translational modification

nitration (Tyr39)

Gene Information

human ... SNCA(6622)

General description

α-Synuclein, Mr 14.5kDa
β-Synuclein, Mr 17kDa

Immunogen

full-length recombinant human α-Synuclein nitrated in vitro

Application

Anti-nitro-α/β-Synuclein (Tyr39) Antibody, clone nSyn14 detects level of nitro-α/β-Synuclein (Tyr39) & has been published & validated for use in WB, IH.
Research Category
Neuroscience
Research Sub Category
Neurodegenerative Diseases

Biochem/physiol Actions

α- or β-synuclein nitrated at Tyr39

Physical form

Ascites
Format: Purified
ascites with 0.05% sodium azide

Preparation Note

2 years at -20°C

Analysis Note

routinely evaluated by immunoblot on recombinant protein nitrated in vitro

Legal Information

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Ta strona może zawierać tekst przetłumaczony maszynowo.

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 1

Ta pozycja
36-00805-882AB5038P
clone

nSyn14, monoclonal

clone

Syn211, monoclonal

clone

PRK8, monoclonal

clone

polyclonal

antibody form

ascites fluid

antibody form

ascites fluid

antibody form

ascites fluid

antibody form

affinity purified immunoglobulin

biological source

mouse

biological source

mouse

biological source

mouse

biological source

rabbit

species reactivity

human

species reactivity

human

species reactivity

human, mouse

species reactivity

rat, human

Gene Information

human ... SNCA(6622)

Gene Information

human ... SNCA(6622)

Gene Information

human ... PARK2(5071)

Gene Information

human ... SNCA(6622)

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100


Still not finding the right product?

Wypróbuj nasze narzędzie Narzędzie selektora produktów, aby zawęzić opcje.


Klasa składowania

10 - Combustible liquids

wgk

WGK 1



Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów



Hugo Vicente Miranda et al.
Scientific reports, 7(1), 13713-13713 (2017-10-24)
Parkinson's disease (PD) is a progressive neurodegenerative disorder known for the typical motor features associated. Pathologically, it is characterized by the intracellular accumulation of alpha-synuclein (aSyn) in Lewy bodies and Lewy neurites. Currently, there are no established biochemical markers for
Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases
Duda, J. E., et al
Annals of Neurology, 52, 205-210 (2002)
J M Souza et al.
The Journal of biological chemistry, 275(24), 18344-18349 (2000-04-05)
Intracellular proteinaceous aggregates are hallmarks of many common neurodegenerative disorders, and recent studies have shown that alpha-synuclein is a major component of several pathological intracellular inclusions, including Lewy bodies in Parkinson's disease (PD) and glial cell inclusions in multiple system



Numer pozycji handlu globalnego

SKUNUMER GTIN
36-01204053252331893

Questions

Reviews

No rating value

Active Filters